Table Of Contents
Key Information 1
Key Ratios 1
Share Data 1
Performance Chart 1
Key Facts 4
Business Description 4
Major Products and Services 5
Overview 5
History 6
SWOT Analysis Overview 7
Overview 7
CardioVascular BioTherapeutics, Inc. - Strengths 7
Proprietary Technology 7
Agreements 7
CardioVascular BioTherapeutics, Inc. - Weaknesses 7
Increased Presence of Debt 7
Dependence on Single Supplier 7
CardioVascular BioTherapeutics, Inc. - Opportunities 8
Market Potential 8
Molecules in Clinical Development 8
Marketing Strategy 8
CardioVascular BioTherapeutics, Inc. - Threats 8
Competition 8
Tightening of FDA’s Regulatory Oversight 8
Emergence of Biogenerics/Biosimilars 9
Key Competitors 10
Key Employees 10
Key Employee Biographies 11
Company Statement 12
Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Financial Ratios 15
Capital Market Ratios 15
Annual Ratios 15
Interim Ratios 15
Ratio Charts 16
Appendix 17
Methodology 17
Ratio Definitions 17
About Global Markets Direct 20
Contact Us 20
Disclaimer 20


List of Tables
CardioVascular BioTherapeutics, Inc., Key Facts 1
CardioVascular BioTherapeutics, Inc., Key Ratios 1
CardioVascular BioTherapeutics, Inc., Share Data 1
CardioVascular BioTherapeutics, Inc., Key Facts 4
CardioVascular BioTherapeutics, Inc., History 6
CardioVascular BioTherapeutics, Inc., Key Employees 10
CardioVascular BioTherapeutics, Inc., Key Employee Biographies 11
CardioVascular BioTherapeutics, Inc., Other Locations 14
CardioVascular BioTherapeutics, Inc., Ratios based on current share price 15
CardioVascular BioTherapeutics, Inc., Annual Ratios 15
CardioVascular BioTherapeutics, Inc., Interim Ratios 15
Currency Codes 17
Capital Market Ratios 17
Equity Ratios 18
Profitability Ratios 18
Cost Ratios 18
Liquidity Ratios 19
Leverage Ratios 19
Efficiency Ratios 19


List of Figures
CardioVascular BioTherapeutics, Inc., Performance Chart (2003 - 2007) 1
CardioVascular BioTherapeutics, Inc., Ratio Charts 16